...Former), infliximab (Generic), Remicade (Other) Novartis AG Amgen Inc. Samsung Bioepis Co. Ltd. Mylan N.V. Sandoz Ltd. IQVia Holdings Inc. Coherus BioSciences Inc. Kaiser Permanente Northern California Merck...

...transcription factor 1 (SIM1) A SNP on SIM1 could help predict the risk of ED Kaiser Permanente Northern California...

...Proc. Natl. Acad. Sci. USA ; published online Oct. 8, 2018 doi:10.1073/pnas.1809872115 CONTACT: Eric Jorgenson, Kaiser Permanente Northern California...
...Calif. email: eric.jorgenson@kp.org CONTACT: Stephen K. Van Den Eeden, same affiliation as above email: stephen.vandeneeden@kp.org Claire Quang Kaiser Permanente Northern California SIM...

...records at a large healthcare system capture those outcomes. The study will include data from Kaiser Permanente Northern California...

...Nat. Commun. ; published online Jan. 31, 2017 doi:10.1038/ncomms14248 CONTACT: Stephen K. Van Den Eeden, Kaiser Permanente Northern California...

...with other large healthcare systems around the country interested in replicating Geisinger’s model, such as Kaiser Permanente Northern California...
...American College of Medical Genetics and Genomics (ACMG), Bethesda, Md. Geisinger Health System, Danville, Pa. Kaiser Permanente Northern California...

...University of Pennsylvania and Kaiser Permanente , the retrospective study includes 193,099 patients from the Kaiser Permanente Northern California...

...observational trial is evaluating new diagnoses of bladder cancer in 193,099 diabetic patients on the Kaiser Permanente Northern California...
...observational trial is evaluating new diagnoses of bladder cancer in 193,099 diabetic patients on the Kaiser Permanente Northern California...

...observational trial is evaluating new diagnoses of bladder cancer in 193,099 diabetic patients on the Kaiser Permanente Northern California...

...observational trial is evaluating new diagnoses of bladder cancer in 193,099 diabetic patients on the Kaiser Permanente Northern California...